Back to Trades
Total Value
$115.0K
Net $115.0K sold
Filing Date
Jul 20, 2026
1 transaction
Sales
$115.0K
1 transaction
Trade Summary
On Jul 16, 2026, BOBULSKY SUSAN, Chief Commercial Officer, MRD, sold $115.0K of Adaptive Biotechnologies Corp (ADPT) across 1 transaction. The filing covers Common Stock and reflects net selling of $115.0K. Reported prices ranged from $23.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Adaptive Biotechnologies Corp
- Ticker Symbol
- ADPT
- CIK
- 0001478320
Insider Information
- Name
- BOBULSKY SUSAN
- Role
- Chief Commercial Officer, MRD
- Location
- SEATTLE, WA
Filing Details
- Filing Date
- Jul 20, 2026
- Transaction Date
- Jul 16, 2026
- Accession Number
- 0001820885-26-000016
- Form Type
- 4
- Net Trading Amount
- -$115.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | 5,000 | $23.00 | Sale | $115.0K |
Want live alerts when BOBULSKY SUSAN trades again?
Download Insider Trades to track ADPT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025.